Home › Narcolepsy › Georgia
Narcolepsy clinical trials in Georgia
7 studies for Narcolepsy are looking for participants at sites in Georgia.
Cities in Georgia
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Neurotrials Research Inc, Atlanta
- Sleep Practitioners, LLC, Macon
- Southeast Lung Associates Research, Rincon
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07675135A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Atlanta, Georgia, Atlanta
- Rincon, Georgia, Rincon
- Stockbridge, Georgia, Stockbridge
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Nov 3, 2026 · NCT07598708A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Atlanta
- Alkermes Investigational Site, Macon
- Alkermes Investigational Site, Stockbridge
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Oct 9, 2026 · NCT06767683A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Centricity Research Rincon - DBA IACT Health Southeast Lung Associates Research, Rincon
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 8, 2026 · NCT07625280A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Macon
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 7, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- NeuroTrials Research, Inc, Atlanta
- Sleep Practitioners, LLC, Macon
- Clinical Research Institute Stockbridge, Stockbridge
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Stockbridge, GA, Atlanta
- Atlanta, Georgia, Atlanta
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.